Polymorphisms of Cx(3)CR1 and CXCR6 receptors in relation to HAART therapy of HIV type 1 patients

AIDS Res Hum Retroviruses. 2007 Aug;23(8):1026-32. doi: 10.1089/aid.2006.0248.

Abstract

The chemokine polymorphisms CXCR6-3E/K, In1.1T/C, H7 haplotype, CX(3)CR1-V249I, and CX(3)CR1-T280M have been shown to affect the course of HIV infection. We studied their influence on immunologic and virologic response to HAART in a group of 143 HIV-1 patients. We performed Kaplan-Meier analysis using the following end-point criteria: (1) time from HAART initiation to undetectable viral load (VL < 50 copies/ml), (2) maximum duration of viral suppression, (3) time from HAART administration until CD4 elevation above 200 cells/microl for patients with baseline CD4 below 200 cells/microl and above 500 cells/microl for patients with baseline CD4 between 200 and 500 cells/microl, respectively, and (4) time from HAART initiation until CD4 reduction below baseline values. Our results revealed an improved immunologic response to HAART in patients with the CX(3)CR1-249I or CX(3)CR1-280M allele. On the contrary, patients with initial VL suppression due to HAART showed a faster virologic failure in the presence of the CXCR6-3K allele. The In1.1T/C polymorphism and H7 haplotype did not reveal any specific effect on HAART response.

MeSH terms

  • Adult
  • Aged
  • Alleles
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • CX3C Chemokine Receptor 1
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / genetics*
  • HIV Infections / virology
  • HIV-1*
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Receptors, CXCR6
  • Receptors, Chemokine / genetics*
  • Receptors, Virus / genetics*
  • Viral Load

Substances

  • CX3C Chemokine Receptor 1
  • CX3CR1 protein, human
  • CXCR6 protein, human
  • Receptors, CXCR6
  • Receptors, Chemokine
  • Receptors, Virus